Thyroid Gland Anatomy and Physiology

Spread the love

The thyroid gland is situated just below the larynx, with its right and left lateral lobes lying on either side of the trachea, connected together by the isthmus. It plays a major role in the metabolism, growth and development of the human body, regulating body functions by constantly releasing a steady amount of thyroid hormones into the bloodstream. It receives a rich blood supply of about 80 to 120ml per minute.

Thyroid Gland Anatomy and Physiology
Retrieved from http://www.aboutcancer.com/thyroid_anatomy.htm on 27th April 2022

Thyroid Gland Histology

The thyroid gland is composed of spherical sacs called thyroid follicles which are covered by a wall made up of Follicular Cells and Parafollicular Cells a.k.a. C Cells.

  • Follicular Cells produce thyroxine (T4) and triiodothyronine (T3). Whilst T4 is usually produced in greater quantities than T3, T3 is up to 4 times more potent than T4. Additionally, about a third of T3 is converted to T4 within peripheral tissues, especially within the lungs and the liver.
  • Parafollicular Cells produce calcitonin (CT).
Thyroid Gland Anatomy and Physiology
Retrieved from https://slideplayer.com/slide/13219076/ on 27th April 2022

Thyroid Hormone Formation, Storage & Release

The thyroid gland is the only endocrine gland that stores its hormonal products in large quantities, eventually releasing them steadily over time. Thyroid hormone formation, storage and release occurs through the following process:

  1. Iodide Trapping – iodide ions are actively transported from the blood to the follicular cells
  2. Thyroglobulin Synthesis – during iodide ion trapping, follicular cells synthesise the glycoprotein Thyroglobulin (TGB) which is released into the thyroid follicle lumen by exocytosis, resulting in colloid accumulation within the lumen and Tyrosine (amino acids) iodination in TGB
  3. Iodide Oxidation – iodide ions bind to TGB following oxidation; simultaneously, iodine is formed by the action of peroxidase
  4. Tyrosine Iodination – formed iodine reacts with tyrosine in the colloid; one iodine atom binding forms monoiodotyrosine (T1); a second iodine atom binding produces diiodotyrosine (T2)
  5. T1 and T2 Coupling – T1 and T2 join and form thyroid hormones
  6. Colloid Pinocytosis & Digestion – colloid droplets re-enter the follicular cells though pinocytosis, and then merge with lysosomes in the follicular cells; lysozyme breaks down TGB, and then produce T3 and T4 molecules
  7. Thyroid Hormone Secretion – lipid-soluble T3 and T4 diffuse through the plasma membrane into the interstitial fluid, and then into the blood; T4 is secreted in larger quantities than T3, yet T3 is much more potent than T4
  8. Transport into Blood – Thyroxine-Binding Globulin (TBG) which is a transport protein found within the blood plasma combine with both T3 and T4 and are carried around in the body within the blood; when T4 enters a cell, most of it is converted to T3 following removal of one iodine

NOTE: Iodine supplements may be given to pregnant women and for compensation of hypothyroidism.

Thyroid Gland Anatomy and Physiology
Retrieved from https://www.pinterest.com/pin/395261304797063744/ on 27th April 2022

Thyroid Hormone Regulation

Thyroid hormone secretion is stimulated by various factors…

hormone regulation
Retrieved from https://quizlet.com/502370009/phys_block-8_-endo-5-6-flash-cards/ on 27th April 2022

Calcitonin (CT)

Calcitonin, which is produced by the parafollicular cells of the thyroid gland, is involved in the homeostasis of blood calcium level:

  • Calcitonin inhibits bone breakdown and promotes bone calcium absorption
  • Calcitonin is used in the treatment of post-menopausal osteoporosis along with calcium and vitamin dietary intake
  • Calcitonin secretion is controlled via a negative feedback system
Calcitonin
Retrieved from https://healthjade.net/calcitonin/ on 27th April 2022

NOTE: Diarrhoea is a possible sign of increased thyroid hormone. Similarly, constipation is a possible sign of underactive thyroid.


Did you find the above nursing information useful? Follow us on Facebook and fill in your email address below to receive new blogposts in your inbox as soon as they’re published 🙂


Spread the love

Diabetes Nursing Management of Complications and Preventative Care

Spread the love

Whilst diabetes preventative care can help avoid the development of type 2 diabetes mellitus, adequate diabetes nursing management can help avoid or reduce the occurrence of serious diabetes complications, such as short-term complications which include hypoglycaemia, diabetic ketoacidosis, hyperosmolar non-ketotic coma, as well as long-term complications which include microvascular and macrovascular complications, and neuropathy.

Short-Term Diabetes Complications

Hypoglycaemia

Hypoglycaemia can be defined as a glucose concentration of 3.9mmol/l or below.

diabetes nursing management
Retrieved from https://www.facebook.com/photo/?fbid=272975211310190&set=a.111544340786612 on 16th April 2022

An individual with hypoglycaemia can be asymptomatic, usually due to adaptation of the brain to chronic hypoglycaemia, which presents with symptoms even at normal blood sugar levels. This can be avoided if the individual experiences a few weeks of good glycaemic control.

An individual with hypoglycaemia may also present with mild symptoms which can be self-managed, severe symptoms requiring medical assistance, and even coma.

diabetes nursing management
Retrieved from https://www.researchgate.net/publication/51746090_Hypoglycemia_Revisited_in_the_Acute_Care_Setting/figures?lo=1&utm_source=google&utm_medium=organic on 16th April 2022

Hypoglycaemia Causes

  • insulin or sulphonylurea overdose (deliberate or accidental) – insulin can cause hypoglycaemia; metformin does not
  • inaccurate injection administration
  • renal and liver impairment cause pharmacokinetic change, possibly leading to a hypoglycaemic episode; individuals with renal and liver impairment should be monitored closely
  • delayed or forgotten meal, or insufficient carbohydrate intake
  • alcohol intake – food needs to be taken with alcohol, otherwise hypogycaemia can be triggered
  • exercise – can trigger a hypoglycaemic episode following exercise or even several hours after
  • hot weather or saunas – insulin is absorbed quicker in warmer temperatures, thus, saunas and hot weather should be avoided
  • honeymoon period (following diagnosis is usually a period a.k.a. honeymoon period in which remaining beta cells may pump out enough insulin to control blood glucose, thus may require less insulin)

Nursing Management of Hypoglycaemia

If the patient presents with mild hypoglycaemia:

  1. give 15-20g of glucose such as a sugary drink – water with 2 teaspoons of sugar
  2. repeat after 10 minutes
  3. check if patient is still hypoglycaemic through HGT testing
  4. if stable give a snack eg. brown bread sandwich to prevent recurrence

NOTE: sugar helps stabilise the patient for that moment; a snack helps maintain glucose level higher for a longer period of time.

If the patient is uncooperative:

Administer GlucoGel (formerly known as Hypostop – raises sugar levels quickly and provides a fast-acting energy boost in the form of Dextrose Gel – 40% dextrose).

NOTE: following a hypoglycaemic episode, ALWAYS ESTABLISH CAUSE eg. problem with insulin administration.

If the patient is unconscious:

  1. adjust patient into the recovery position
  2. administer glucagon by intramuscular or subcutaneous injection OR 50cc of 50% dextrose intravenously.

Preventative Measures

The older person is at increased risk of suffering from fall injuries, heart attacks and strokes during hypoglycaemic episodes. Thus, teach older adults at risk of hypoglycaemia:

  • to carry an ID bracelet at all times
  • to check their blood glucose levels prior to risky activities
  • to know and identify early signs of an impending hypoglycaemic episode

Diabetic Ketoacidosis

Diabetic Ketoacidosis is the most acute state of Type 1 Diabetes. Diabetic Ketoacidosis onset may be both gradual or sudden, and is characterised by the following findings:

  • hyperglycaemia (15.0mmol/l and over)
  • ketonuria (if cells are not supplied with enough glucose, the body burns fat for energy whilst producing ketones which can show up in the blood and urine, evident in a urine dipstick test)
  • pH of 7.3 or less (normal blood pH level is 7.35 to 7.45)

Common causes for DKA include:

  • infection – most common cause of DKA eg. gastroenteritis, flu, small infection etc.
  • stressors – traumatic injuries and/or increased stress
  • insulin cessation – common in adolescents; patients need to be reminded that diabetes is a condition for life, thus needs to be controlled with ongoing treatment
  • anuria (not passing urine) – a minimum of 30ml/hr of urine should be passed
  • not eating – increases risk of DKA
diabetes nursing management
Retrieved from https://slideplayer.com/slide/6428754/ on 17th April 2022
Retrieved from https://eliteayurveda.com/blog/3-main-symptoms-or-3ps-of-diabetes/ on 25th June 2022

Kussmaul Breathing

Kussmaul Breathing is a sign of DKA. It is characterised by sweet-smelling breath which is rapid and deep. It manifests as a compensatory mechanism due to build-up of carbon dioxide and lack of oxygen.

diabetes nursing management
Retrieved from https://www.aafp.org/afp/2013/0301/p337.html on 17th April 2022
diabetes nursing management
Retrieved from https://nurseyourownway.com/2016/03/21/sickly-sweet-understanding-diabetic-ketoacidosis/ on 17th April 2022

Diabetes Nursing Management of DKA

An individual with DKA needs:

  • treatment for hyperglycaemia – patient needs to be kept nil-by-mouth along with administration of a continuous low dosage of insulin by IV pump. NOTE: monitor blood glucose levels and ensure it isn’t lowered at a rate faster than 5mmol/hr to avoid cerebral oedema.
  • treatment for dehydration, electrolyte imbalance, and acidosis – patient needs administration of IV fluids with electrolytes (eg. Hartmann’s – a clear solution of sodium chloride, potassium chloride, calcium chloride dihydrate and sodium lactate 60% in water) to help with dehydration and electrolyte imbalance, and insulin, which usually also corrects acidosis without the need for sodium bicarbonate administration. NOTE: monitor serum potassium levels and ECG tracings to ensure correct potassium level is achieved, and monitor for signs of fluid overdose. NOTE: if not NBM, patient should be encouraged to drink high-carb drinks eg. broth, soup, juices etc.
  • treatment for precipitating factors – DKA is commonly induced by infection, thus, antibiotic therapy should begin following C&S specimen, wound drainage, or blood results are obtained.

NOTE: If patient is sick with flu/cold etc., blood glucose needs to be monitored, insulin needs to be administered still. Within the body, carbs start to be broken down in an attempt to avoid going into DKA. Monitoring carb intake to avoid going into hyperglycaemia is recommended.

Additionally, monitor frequently the patient’s:

  • vital signs: blood pressure, pulse, temperature, and respirations
  • level of consciousness
  • intake and output
  • urine
  • blood glucose
  • ketone bodies
  • GFR renal profile – to check kidney function and serum electrolytes
  • HbA1c – to monitor glucose for the past 3 months
  • CBC – to check volume of white blood cells (low white blood cell count may be a sign of infection which could have been the reason behind the patient going into DKA
  • ABGs, serum K levels, urea, and RBGs – to check the partial pressure of CO2 and to see if the patient is going into respiratory acidosis; tests also give an indication of electrolyte status (eg. potassium is lost in DKA due to polyuria, and kidney function may become impaired, causing electrolyte imbalance)
  • ECG (due to risk of cardiac arrest from hypokalaemia)

and ensure that the patient:

  • receives mouth care due to NBM and dehydration
  • for dehydration encourage patient to drink water unless NBM, in which case, IV fluids should be administered – monitor fluid intake and output!
  • is cared for in case of pain (assess for need of analgesics), abdominal pain, nausea (administer antiemetics) and vomiting (provide vomiting bags just in case)
  • is kept safe (attention: side rails, frequent turnings, call bell at arms’ length, and skin care)
  • airway patency is maintained (if unconscious)
  • always provide reassurance (helps reduce patient anxiety)

DKA Possible Treatment Complications:

  • hypokalaemia
  • hypotension
  • dehydration
  • impaired renal function
  • cardiac arrest
  • HAIs – ensure proper infection control principles are maintained so as to avoid patient getting an infection (may already be infected since infection is one of the problems leading to DKA)

When DKA is resolved:

  • insulin is administered subcutaneously (insulin IV should be continued for 1hr following SC insulin injection)
  • food is provided 30 minutes following insulin administration
  • monitor for DKA recurrence
  • teach patient ways to prevent recurrence

Hyperosmolar Non-Ketotic Coma

Hyperosmolar non-ketotic coma usually happens in individuals who have not been diagnosed with diabetes, usually type 2 diabetes, and is more common in individuals over 60 years of age. Characteristics are usually less severe, and most commonly develop over a long period of time.

Characteristics of hyperosmolar non-ketotic coma include:

  • hyperglycaemia
  • dehydration
  • no ketoacidosis

Nursing Management of Hyperosmolar Non-Ketotic Coma

Patients with Hyperosmolar Non-Ketotic Coma need to be treated in the same way as in Diabetic Ketoacidosis EXCEPT:

  • if serum Na (Sodium) is MORE THAN 155mmol/l use 0.45% NaCl instead of 0.9% NaCl
  • patient may require insulin infusion at a lower rate
  • patient should be administered an anticoagulant due to an increased risk for thromboembolism
  • patient should have central venous pressure catheter

NOTE: following resolution, patient may require insulin subcutaneously for a few weeks before transitioning to new treatment regimen consisting of diet, exercise, and hypoglycaemic agents.

Long-Term Diabetes Complications

Microvascular Complications

Microvascular complications of diabetes are long-term complications which affect small blood vessels. Complications typically include:

  • retinopathy – retina disease (most common cause of blindness in young people)
  • nephropathy – kidney function deterioration (affects 45% of diabetic patients, 25% of which develop end-stage renal disease)
  • peripheral neuropathy – impaired sensation in the peripheries (feet and hands)
  • autonomic neuropathy – bowel and bladder disorders

MACROVASCULAR COMPLICATIONS

Macrovascular complications of Type 2 Diabetes are primarily diseases of the coronary arteries, peripheral arteries, and cerebrovasculature. Cardiovascular disease is the primary cause of death in diabetic patients. Early macrovascular disease is associated with atherosclerosis.

Preventative Measures for Microvascular and Macrovascular Complications

  • in patients with stable glycaemic control assess glycaemic status through A1C or other glycaemic measurements at least every 6 months
  • in patients with unstable glycaemic control and/or who have had recent treatment change assess glycaemic status through A1C at least every 3 months
  • promote lipid management through the Mediterranean Diet or DASH, reduction of saturated fat and trans fat intake, increase in healthy fats intake, viscous fiber, plant sterols intake (found in vegetable oils, nuts and seeds), and increased physical activity to prevent atherosclerosis development
  • promote optimum glycaemic control in patients with triglyceride levels of >150mg/dL (1.7mmol/L) and low HDL Cholesterol amounting to <40mg/dL (1.0mmol/L) in men and <50mg/dL (1.3mmol/L) in women
  • screen for renal disease at least yearly through urinary-albumin-to-creatinine ratio and estimated glomerular filtration rate (EGFR) in individuals with 5 years or more of type 1 diabetes, and in all individuals with type 2 diabetes (monitor every 6 months patients with >300mg/g creatinine and EGFR 30-60mL/min/1.73m2)
  • refer to ophthalmologist for eye complication screening patients with type 1 diabetes within 5 years of diabetes diagnosis, and patients with type 2 diabetes upon diabetes diagnosis
  • provide general preventative diabetic foot self-care education to all patients with diabetes, and refer to registered podiatrist for annual foot evaluation to identify risk factors for ulcer formation and amputations

Statin Therapy

Retrieved from https://www.uchealth.org/ on 23rd April 2022

CVD Risk Assessment Tool for Healthcare Professionals

ESC CVD Risk Calculation App (Apple or Android)


Did you find the above nursing information useful? Follow us on Facebook and subscribe to receive new blogposts by email as soon as they’re published 🙂


Spread the love

Female Reproductive System

Spread the love

The female reproductive system consists of the following organs:

  • ovaries – produce secondary oocytes and hormones (progesterone, oestrogens, relaxin, and inhibin)
  • fallopian tubes – the sites where fertilisation normally occurs; additionally assist in transporting a secondary oocyte to the uterus
  • uterus – cavity in which a fertilised ovum implants, and develops into a fetus for pregnancy and labour
  • vagina – the site which receives the penis during sexual intercourse, and which acts as a passageway during childbirth
  • external organs / vulva / pudendum
female reproductive system
Retrieved from https://www.slideserve.com/csilla/anatomy-and-physiology-the-female-reproductive-system on 9th April 2022

The Ovaries

The ovaries are a pair of irregularly scarred surfaced pale white glands measuring between 2.5 to 3.5cm long, 2cm wide, and 1.25cm thick. They produce gametes, which are secondary oocytes that develop into mature ova following fertilisation, and the hormones oestrogen, progesterone, inhibin, and relaxin.

The ovaries are held in place by 3 types of ligaments, namely the broad ligament of the uterus, which is part of the parietal peritoneum that attaches to the ovaries by the mesovarium; the ovarian ligament, which anchors the ovaries to the uterus; and the suspensory ligament, which attaches the ovaries to the pelvic walls.

female reproductive system
Retrieved from https://quizlet.com/180196971/female-reproductive-system-flash-cards/ on 15th April 2022

Each ovary consists of:

GERMINAL EPITHELIUM – a layer of simple epithelium which covers the ovary’s surface and is continuous with the mesothelium that covers the mesovarium. The germinal epithelium does not give rise to ova.

TUNICA ALBUGINEA – a whitish capsule of dense irregular connective tissue found right beneath the germinal epithelium.

OVARIAN CORTEX – consists of ovarian follicles which are surrounded by dense irregular connective tissue containing scattered smooth muscle cells. The ovarian cortex can be found right beneath the tunica albuginea.

OVARIAN MEDULLA – consists of loose connective tissue which contains blood vessels, lymphatic vessels, and nerves.

OVARIAN FOLLICLES – consist of oocytes in various developing phases and surrounding cells which provide nourishment to the oocytes and secrete oestrogens throughout the follicle’s growing phase; single-layered surrounding cells are referred to as follicular cells, while multiple-layered surrounding cells are referred to as granulosa cells.

GRAAFIAN FOLLICLE – large follicle full of fluid in a close-to-being-ruptured state.

CORPUS LUTEUM – contains the remnants of the mature follicle, following ovulation; the corpus luteum produces progesterone, oestrogens, relaxin, and inhibin, before turning into fibrous scar tissue referred to as the corpus albicans.

Retrieved from https://slideplayer.com/slide/8162919/ on 15th April 2022

The Fallopian Tubes

The fallopian tubes are two hollow fibromuscular cylinders lined by epithelium which extend outwards and backwards around 10cm from the uterine cornu to the ovaries. Each fallopian tube is divided into the following parts:

  1. interstitial (approx. 0.7mm x 2.5cm)
  2. isthmus (approx. 1mm x 2.5cm)
  3. ampulla (approx. 6mm x 5cm)
  4. infundibulum (approx. 10mm wide)
female reproductive system
Retrieved from https://www.britannica.com/science/uterus on 15th April 2022

The fallopian tubes are made up of 3 layers:

INTERNAL MUCOSA – contains ciliated columnar epithelial cells that help move the fertilised ovum along the tube.

MUSCULARIS – is the middle layer. It is composed of an inner circular ring of smooth muscle and an outer thin region of longitudinal smooth muscle; peristaltic contractions of the muscularis along with the ciliary action of the mucosal cells assist the oocyte or fertilised ovum to move towards the uterus.

SEROSA – the outer layer of the fallopian tubes.

The Uterus

The uterus is a pear-shaped hollow organ that projects anteriorly and superiorly over the urinary bladder, measuring about 7.5cm x 5cm at the fundus, and 2.5cm from front to back. The uterine wall thickness measures around 1 to 2cm.

The uterus features the following anatomical subdivisions:

  • fundus – dome-shaped portion superior to the fallopian tubes
  • body – tapering entral portion
  • cervix – inferior narrow portion which opens into the vagina; projects inferiorly and posteriorly, and enters the vaginal wall at almost a right angle
  • isthmus – constricted region measuring around 1cm long found between the body and the cervix

The uterine cavity is the uterine body’s inferior. The cervical canal is the interior of the narrow cervix. The cervical canal opens into the uterine cavity at the internal os into the vagina at the external os.

female reproductive system
Retrieved from https://courses.lumenlearning.com/boundless-ap/chapter/the-female-reproductive-system/ on 15th April 2022

The uterus is made up of 3 layers:

PERIMETRIUM – the outer layer of the uterus becomes the broad ligament laterally, covers the urinary bladder and forms the vesicouterine pouch anteriorly, and covers the rectum and forms the rectouterine pouch a.k.a. pouch of Douglas posteriorly.

MYOMETRIUM – the middle layer of the uterus is thickest and circular in the fundus area and the thinnest and longitudinal in the cervix area; the myometrium responds to oxytocin released by the pituitary during labour and childbirth through contraction coordination which help in expelling the fetus from the uterus.

ENDOMETRIUM – the inner layer of the uterus is highly vascular. It is divided into two layers: the stratum functionalis lines the uterine cavity and sloughs off during menstruation, and the stratum basalis, which is a permanent layer, gives rise to a new stratum functionalis following each menstruation.

Retrieved from https://socratic.org/questions/what-are-the-two-layers-of-the-endometrium on 15th April 2022

Cervical Mucus

Cervical mucus is a secretion produced by the secretory cells of the cervix’s mucosa. It consists of water, glycoprotein, lipids, enzymes, and inorganic salts. Females in their fertile years secrete between 20-60ml of cervical mucus daily, which is more hospitable to sperm at or close to ovulation, when it is less viscous and increasingly alkaline with a pH of 8.5. Viscous mucus forms the cervical plug which stops sperm penetration.

The Vagina

The vagina is a long tubular fibromuscular canal measuring approximately 10cm long which extends from the exterior of the body to the cervix. It acts as a receptacle for the penis during sexual intercourse, an outlet for menstruation, and a passageway during childbirth.

The vaginal mucosa, which is continuous with the uterine mucosa, contains large glycogen stores that, upon decomposing, produce organic acids, which lead to a resulting acidic environment which retards microbial growth.

The Vulva

The vulva a.k.a. pudendum, is the female’s external genitalia. It consists of the following:

  • mons pubis
  • labia majora
  • labia minora
  • clitoris
Retrieved from https://www.cancer.org/cancer/vulvar-cancer/about/what-is-vulvar-cancer.html on 15th April 2022

Mammary Glands

The mammary glands, which lie over the pectoralis major and the serratus anterior, are modified sweat glands which produce milk.

Functions of the breast in relation to lactation include:

  • milk synthesis
  • milk secretion
  • milk ejection

NIPPLE – pigmented projection.

LACTIFEROUS DUCTS – closely spaced duct openings which allow milk ejection.

AREOLA – circular rough-looking pigmented area surrounding the nipple which contains modified sebaceous glands.

SUSPENSORY LIGAMENTS OF THE BREAST A.K.A. COOPER’S LIGAMENTS – strands of connective tissue found between the skin and the deep fascia that provides support for the breast.

MILK – following production, milk passes from the milk-secreting alveoli into secondary tubules, and then into mammary ducts. Mammary ducts close to the nipple expand and form lactiferous sinuses, where milk is stored, and is eventually drained into the lactiferous ducts, which drain into the exterior.

Retrieved from https://www.brainkart.com/article/Mammary-Glands—Anatomy-and-Physiology_18849/ on 16th April 2022

Hormones Related to the Female Reproductive System

female reproductive system
Retrieved from http://www.pharmacy180.com/article/pituitary-gland-3595/ on 5th March 2022

Follicle-Stimulating Hormone (FSH)

  • in females initiates the development of an ova every month, and stimulates cells within the ovaries to secrete oestrogens
  • in males stimulates the testes to produce sperm
  • secretion depends on the hypothalamic regulating factor gonadotropin releasing factor (GnRF), which is released in response to oestrogens in females, and to testosterone in males through a negative feedback system

Luteinizing Hormone (LH)

  • along with oestrogens, in females it stimulates the release of an ovum within the ovary, prepares the uterus for the implantation of the fertilised ovum, stimulates the formation of the corpus luteum in the ovary to secrete progesterone, and prepares the mammary glands for milk secretion
  • in males it stimulates the interstitial endocrinocytes in the testes to develop and secrete testosterone
  • secretion is controlled by GnRF, which works through a negative feedback system

Prolactin (PRL)

  • requires priming of the mammary glands through oestrogens, progesterone, corticosteroids, growth hormone, thyroxine, and insulin
  • initiates and maintains milk secretion by the mammary glands (amount of milk is determined by oxytocin)
  • has an inhibitory and an excitatory negative control system
  • level rises during pregnancy, falls right after delivery, and rises again during breastfeeding, which is why in the 1st two days following birth, mothers do not produce milk but colostrum

NOTE: women on oral contraceptives may experience lack of milk production due to their hormonal effect.

Pituitary Gland Posterior Lobe

The posterior lobe of the pituitary gland a.k.a. neurohypophysis, does not synthesise hormones. It releases hormones to the circulation via the posterior hypophyseal veins to be distributed to target cells in other tissues. The cell bodies of the neurosecretory cells produce Oxytocin (OT) and Antidiuretic Hormone (ADH) / Vasopressin.

Oxytocin (OT)

  • is released in high amounts just before birth
  • stimulates contraction of smooth muscle cells in the pregnant uterus
  • stimulates the contractile cells around the mammary gland ducts
  • affects milk ejection
  • works through a positive feedback cycle which is broken following birthing
  • is inhibited by progesterone, but can work in conjunction to oestrogens
female reproductive system
Retrieved from https://basicmedicalkey.com/uterine-drugs/ on 16th April 2022

The Female Reproductive Cycle

The female reproductive cycle a.k.a. menstrual cycle demonstrates regular cyclic changes seeming as periodic preparations for fertilisation and pregnancy, which, if unsuccessful, results in menstruation where the uterine mucosa (stratum functionalis portion of the endometrium) is shed.

The ovarian cycle features a series of events related to the maturation of an ovum which usually occurs on a monthly basis.

Oestrogen

  • Oestrogen assists in the development and maintenance of the endometrial lining of the uterus, secondary sex characteristics, and breasts
  • Oestrogen helps keep fluid and electrolyte balance
  • Oestrogen increases protein anabolism (process in which amino acids are transformed into proteins) and is synergistic with the Growth Hormone a.k.a. Somatotropin
  • Oestrogen helps in keeping a low blood cholesterol level

NOTE: Moderate levels of oestrogens in the blood inhibit GnRF (Gonadotropin-Releasing Hormone) release by the hypothalamus. This causes the inhibition of FSH (Follicle Stimulating Hormone) secretion by the anterior pituitary gland.

pROGESTERONE

  • Progesterone works in conjunction with Oestrogen in preparing the endometrium for implantation of a fertilised ovum, and in preparation of the mammary glands for milk secretion

NOTE: High levels of progesterone inhibit GnRF (Gonadotropin-Releasing Hormone) and LH (Luteinizing Hormone).

Inhibin

  • Inhibin inhibits the secretion of FSH (Follicle Stimulating Hormone) and LH (Luteinizing Hormone). This happens so as to inhibit multiple ovum maturation following the release of a mature ovum following ovulation.

Relaxin

  • Relaxin helps relax the uterus through the inhibition of myometrium contractions
  • Relaxin is produced by the placenta during pregnancy to help increase relaxation of the uterine smooth muscle
  • Relaxin increases the flexibility of the pubic symphysis near the end of pregnancy, and may also help in the cervix dilation process in preparation for childbirth
female reproductive system
Retrieved from https://www.easynotecards.com/notecard_set/85750 on 16th April 2022

The Menstrual Cycle

Retrieved from https://sofreshnsogreen.com/wellness/cycle-syncing-guide/ on 16th April 2022

The menstrual cycle can be divided into 3 phases:

THE MENSTRUAL PHASE – the periodic discharge of 25ml to 65ml of blood, tissue fluid, mucus and epithelial cells, caused by a sudden reduction in oestrogens and progesterone. This phase usually lasts for around 5 days.

  1. During this phase, 20 to 25 primary follicles start to produce small amounts of oestrogens.
  2. By the end of menstruation, around 20 of these primary follicles develop into secondary follicles, while surrounding cells increase in number, differentiate, and secrete follicular fluid.
  3. The follicular fluid forces an immature ovum to the edge of the secondary follicle and fills the follicular cavity, whilst secondary follicles produce oestrogens, leading to an elevation of oestrogen levels in the blood.
  4. Ovarian follicle development results from GnRF secretion by the hypothalamus, which then stimulates high FSH production by the anterior pituitary.

THE PREOVULATORY PHASE – the second phase of the menstrual cycle which covers the phase between menstruation and ovulation.

  1. FSH and LH stimulate ovarian follicles to increase oestrogen production, which stimulates the rebuilding of the endometrium, which by the end of this phase doubles to up to 6mm.
  2. With the thickening of the endometrium, short straight endometrial glands develop, and arterioles coil and lengthen whilst penetrating the functionalis.
  3. LH is secreted in increasing quantities as this phase starts to near its end.
  4. A secondary follicle matures into a vesicular ovarian a.k.a. graafian follicle, ready for ovulation. At this time, just before ovulation occurs, the vesicular ovarian starts producing small amounts of progesterone.

OVULATION – the immature ovum in the vesicular ovarian follicle is released into the pelvic cavity around the middle of the menstrual cycle.

  1. Immediately prior to ovulation, high levels of oestrogen inhibit GnRF production by the hypothalamus, which in turn inhibits FSH secretion by the anterior pituitary via a negative feedback effect.
  2. At the same time, high levels of oestrogen work through a positive feedback effect, causing the anterior pituitary to release a high amount of LH which triggers ovulation.
  3. Following ovulation, the vesicular ovarian follicle collapses, the follicular cells enlarge, change, and form the corpus luteum.

THE POSTOVULATORY PHASE – represents the time between ovulation and onset of upcoming menses. This phase is consistent in duration.

  1. Following ovulation, LH secretion stimulates the development of the corpus luteum.
  2. The corpus luteum secretes increasing quantities of oestrogens and progesterone.
  3. FSH secretion increases gradually whilst LH secretion decreases.
  4. During this phase, progesterone becomes the most dominant ovarian hormone.

SEQUELAE

  1. If fertilisation and implantation do not occur, the increasing progesterone and oestrogen levels secreted by the corpus luteum inhibit GnRF and LH secretion.
  2. The corpus luteum degenerates, which causes decreased secretion of progesterone and oestrogens.
  3. The corpus luteum becomes the corpus albicans, whilst the decrease in progesterone and oestrogens trigger another menstrual cycle to begin, along with increased output of GnRF by the hypothalamus and a new output of FSH.
Retrieved from https://quizlet.com/au/232342424/hormonal-control-of-menstrual-cycle-diagram/ on 16th April 2022

Conditions & Operations Related to the Female Reproductive System

Hysterectomy

Hysterectomy is the most common gynaecological operation, commonly indicated in endometriosis, pelvic inflammatory disease, recurrent ovarian cysts, excessive uterine bleeding, and cancer of the cervix, uterus, or ovaries.

There are 3 types of hysterectomies:

  1. Total Hysterectomy – removal of the uterine body and cervix
  2. Partial Hysterectomy – removal of uterine body only (cervix is left in situ)
  3. Radical Hysterectomy – removal of uterine body, cervix, fallopian tubes (and possibly the ovaries), the vagina’s superior portion, the pelvic lymph nodes, and supporting structures
Retrieved from https://www.gleneagles.com.sg/specialties/medical-specialties/women-gynaecology/hysterectomy on 15th April 2022

Cystocoele

Cystocoele is a herniation of the bladder wall into the vaginal cavity.

Retrieved from https://www.chicagourogynecologist.com/center-services/pelvic-organ-prolapse/cystocoele/ on 14th April 2022

Rectocoele

Rectocoele is a herniation of the rectum into the vaginal wall.

Retrieved from https://fascrs.org/patients/diseases-and-conditions/a-z/rectocele-expanded-information on 14th April 2022

Did you find the above nursing information useful? Follow us on Facebook and subscribe to receive new blogposts by email as soon as they’re published 🙂


Spread the love

Male Reproductive System

Spread the love

The male reproductive system consists of the following organs:

  • testes
  • ducts system (ductus deferens, ejaculatory ducts, urethra)
  • accessory sex glands (seminal vesicles, prostate gland, bulbourethral gland)
  • supporting structures (scrotum, penis)

The function of the testes is to produce sperm and secrete hormones, while the ducts system is responsible for the transportation and storage of sperm, assistance in sperm maturation, as well as conveyance of the sperm to the exterior.

male reproductive system
Retrieved from https://www.slideserve.com/coy/chapter-28-the-reproductive-systems on 5th April 2022

The Scrotum

The scrotum acts as a supporting structure for the testes, consisting of loose skin and superficial fascia that hangs from the root of the penis. The left testis is suspended lower than the right testis. The spermatic cord passes up the scrotum’s back, through the inguinal ring, and into the pelvic cavity.

The external structure of the scrotum consists of rich sensory innervation, sebaceous glands, darker pigmentation, and sparse hair.

Within the internal structure of the scrotum is the scrotal septum (made up of the superficial fascia and the dartos muscle), which divides the scrotum into 2 sacs.

The testes are kept cooler by the following 3 structures:

  • cremaster muscle of the spermatic cord – relaxes when warm, contracts when cool, thus raising or lowering the scrotum and testes
  • dartos muscle in the scrotal wall – contracts and tautens the scrotum when cool
  • pampiniform plexus of blood vessels in the spermatic cord – acts as countercurrent heat exchanger, cooling blood on its way to the testis
male reproductive system
Retrieved from https://en.wikipedia.org/wiki/Scrotal_septum on 5th April 2022
male reproductive system
Retrieved from https://www.rrnursingschool.biz/unity-companies/scrotum.html on 5th April 2022

The Testes

The testes are paired oval glands measuring around 5cm long with a diameter of 2.5cm. Each testis weighs between 10-15g. During foetal development, the testes originate near the kidneys, from where they start descending through the inguinal canals towards and into the scrotum by the end of the 7th month of pregnancy.

The testis has a fibrous capsule known as Tunica Albuginea. Within the fibrous septa are up to 300 compartments known as lobules, each of which contains up to 3 sperm-producing seminiferous tubules. Between these tubules are clusters of interstitial cells which secrete testosterone.

Retrieved from https://radiopaedia.org/cases/testis-cross-section?lang=us on 5th April 2022

The Seminiferous Tubules

The seminiferous tubules contain the following two types of cells:

  1. spermatogenic cells – produce sperm
  2. sertoli cells – support spermatogenesis
male reproductive system
Retrieved from https://microbenotes.com/spermatogenesis/ on 5th April 2022

Sertoli Cells

Sertoli cells, a.k.a. sustentacular cells, support and protect spermatogenic cells through their development.

Retrieved from https://www.nagwa.com/en/videos/104129276305/ on 5th April 2022

Leydig Cells

Leydig cells a.k.a. interstitial endocrinocytes, are found in clusters within the spaces between adjacent seminiferous tubules. They secrete testosterone.

Retrieved from https://histology.siu.edu/erg/RE028b.htm on 7th April 2022

The Ducts

Sperm cells pass through a number of ducts to exit the body. Once they leave the testes, sperm cells pass through the epididymis, ductus deferens, ejaculatory duct, and urethra.

EFFERENT DUCTULES – carry sperm from the posterior side of the testis to the epididymis thanks to ciliated cell clusters which assist the sperm through.

EPIDIDYMIS – whilst travelling through the epididymis, sperm cells mature, and are then stored in the epididymis’s tail, where they remain fertile for 40 to 60 days.

DUCTUS DEFERENS – sperm cells travel from the epididymis’s tail before uniting with the seminal vesicle duct.

EJACULATORY DUCT – allows the sperm cells through the prostate gland before emptying into the urethra.

SEMINIFEROUS TUBULES – open up into a collection of very short ducts known as straight tubules, which lead into the rete testis.

EFFERENT DUCTS – sperm moves into a series of coiled ducts within the epididymis.

DUCTUS EPIDIDYMIS – efferent ducts empty into a single tube a.k.a. ductus epididymis.

Retrieved from https://quizlet.com/213934544/chapter-27-male-reproductive-system-flash-cards/ on 7th April 2022

Accessory Sex Glands within the Male Reproductive System

male reproductive system
Retrieved from https://www.flexiprep.com/NIOS-Notes/Secondary/Science/NIOS-Class-10-Science-Chapter-24-Reproduction-Part-2.html on 7th April 2022

Seminal Vesicles

Seminal Vesicles are a pair of glands associated with the ductus deferens, posterior to the urinary bladder base and anterior to the rectum. Seminal vesicles secrete an alkaline yellowish secretion, which helps in neutralising the acidic environment of the male urethra and the female reproductive tract. It totals about 60% of semen, containing Fructose (used for sperm ATP production), Prostaglandins (provide sperm motility and viability), and Clotting Proteins (promote semen coagulation following ejaculation).

Prostate Gland

The prostate gland is a single gland situated immediately inferior to the bladder, surrounding the urethra and the ejaculatory duct. It secretes a thin, milky, slightly acidic secretion totaling around 30% of semen, containing Citric Acid (used for sperm ATP production via Krebs’ cycle), Proteolytic Enzymes (promote breakdown of clotting proteins from the seminal vesicles), and Acid Phosphatase.

Bulbourethral a.k.a. cowper glands

Bulbourethral Glands a.k.a. Cowper’s Glands, are pea-sized glands located posterior to the prostate. They produce a clear, slippery fluid during sexual arousal, which helps lubricate the penis’s head in preparation for intercourse. It also neutralises the acidity of residual urine found in the urethra, since this acidity would be harmful to the sperm.

The Penis

The penis provides a passageway for sperm ejaculation and urine excretion through the urethra. It consists of the Root (attached portion), the Body (2 corpora cavernosa, and 1 corpus spongiosum), and the Glans penis.

male reproductive system
Retrieved from https://www.uptodate.com/contents/image?imageKey=EM%2F76391&topicKey=PEDS%2F6587&source=see_link on 7th April 2022

Hormones related to the Male Reproductive System

ANDROGENS – masculinising steroid sex hormones eg. testosterone (normally secreted in both sexes)

OESTROGENS – feminising steroid sex hormones (normally secreted in both sexes)

PITUITARY GONADOTROPHINS – FSH (follicle-stimulating hormone) helps in maintaining spermatogenic epithelium and sertoli cells within the male, and LH (luteinizing hormone) stimulates testosterone production from the Leydig Cells within the testes.

male reproductive system
Retrieved from https://www.austincc.edu/apreview/PhysText/Reproductive.html on 7th April 2022

Testosterone

Testosterone, which is the primary hormone in the testes:

  • promotes male development
  • is responsible for an inhibitory feedback response on the pituitary’s secretion of LH
  • develops and maintains male secondary sex characteristics eg. body hair growth, larynx enlargement and voice deepening, increased stature, etc.
  • exerts a protein anabolic, growth-promoting effect
  • maintains gametogenesis, along with FSH

Testicular Function Control

FSH:

  • maintains gametogenic function, along with androgens
  • is tropic to the Sertoli cells
  • stimulates secretion of androgen-binding protein and inhibin (inhibin feeds back to inhibit FSH secretion)

LH:

  • stimulates testosterone secretion (testosterone feeds back to inhibit LH secretion)
  • is tropic to the Leydig cells

Did you find the above nursing information useful? Follow us on Facebook and subscribe to receive new blogposts by email as soon as they’re published 🙂


Spread the love

Infection Control Measures in Immunosuppressed Patients

Spread the love

Infection complications are most often predictable and possibly preventable through adequate infection control measures. In immunosuppressed patients this is of high importance, especially since the greater the impairment, the higher the risk of infection. Recognising patients with increased risk, identifying and correcting risk factors in advance, and reducing sources of infection are important aspects related to prevention of infection.

Immunosuppressed Patients

Immunosuppressed patients typically are those patients who have:

  • extensive burns
  • organ transplants
  • particular genetic disorders eg. immunoglobulin A deficiency
  • HIV infections
  • leukaemias (cancer of white blood cells)
  • lymphomas (cancer of the lymphatic system)
  • high-dose chemotherapy
  • haematological malignancies (cancers originating in blood-forming tissue eg. bone marrow, or in immune system cells)
  • neutropenia (lack of neutrophils)

Neutropenia

Neutropenia is characterised by lack of neutrophils – white blood cells that help fight infections, especially those caused by bacteria. Normal range for neutrophils is 2.5-7.5 x 109/L. The lower the neutrophil count, the steeper the fall or the longer the duration of neutropenia, the higher the risk of infection.

immunosuppressed patients
Retrieved from https://www.haematologica.org/article/view/7075 on 2nd April 2022
immunosuppressed patients
Retrieved from https://www.aafp.org/afp/2015/1201/p1004.html on 2nd April 2022

Protective Precautions vs Protective Isolation

COMMENSAL MICRO-ORGANISMS – can be found on body surfaces which are covered by epithelial cells and exposed to the external environment (GI tract, respiration tract, vagina, skin, etc).

COMMENSAL BACTERIA – although co-evolved with their hosts, in specific circumstances can overcome protective responses in the host, causing pathologic effects.

NOSOCOMIAL INFECTIONS – eg. healthcare associated infections & MRSA.

OPPORTUNISTIC INFECTIONS – infections affecting solely the immunosuppressed patient eg. Kaposi’s sarcoma.

Infection-causing micro-organisms in immunosuppressed patients may be acquired through:

  • the presence of the individual’s normal flora
  • hospital staff hands
  • hospital equipment
  • food

Protective isolation components include:

  • physical separation from the main population through the use of a single room
  • restriction on movement, visitors and diet
  • antimicrobial prophylaxis and selective decontamination of the digestive system
  • care for the maintenance of skin and mucous membrane integrity
  • application of hand hygiene to prevent exogenous acquisition of micro-organisms

NOTE: Signs & symptoms of infection are most commonly absent in immunosuppressed patients.

Transferring an immunosuppressed patient in Protective Isolation may not be enough to prevent subsequent development of infection.

infection control measures
Retrieved from https://studylib.net/doc/18818582/protective-precautions on 2nd April 2022

Infection Control Measures

Infection control measures help prevent infection in immunosuppressed patients. Standard precautions should be applied when caring for neutropenic patients as well as severely immunosuppressed patients.

ComponentRecommendations
Hand hygieneafter contact with body fluids (including contaminated items), after glove removal, and between one patient and another
Glovesuse when touching body fluids (including contaminated items), when touching mucous membranes, and non-intact skin
Gownuse during procedures and patient care which require contact with clothing and exposed skin with anticipated exposure to body fluid
Face protection (eg. masks, goggles, visors)use during procedures and patient care which are likely to generate splashes of body fluids, including aerosol-generating procedures with suspected or proven infections that transmit by respiratory aerosols (in which case wear an N95 or higher respirator along with gloves, gown, face and eye protection)
Soiled equipmenthandle using preventative measures to avoid transferring micro-organisms to other individuals and to the environment; perform hand hygiene and wear gloves when handling visibly contaminated items
Environmental controlsupport/advocate for routine care, cleaning and disinfection of surroundings, especially surroundings close to patient-care areas

Standard Precautions

Textiles and laundryhandle using preventative measures to avoid transferring micro-organisms to other individuals and to the environment
Sharpsavoid recapping, bending, breaking or manipulating used needles; if recapping is needed, use one-hand scoop technique; use safety features if available; use appropriate sharps disposal containers
Patient resuscitationuse mouthpiece, resuscitation bag, or other ventilation devices to prevent oral contact and contact with oral secretions
Patient placementuse single-patient room if patient is at increased risk of transmission, contamination, lacking hygiene maintenance, or if patient is at increased risk of becoming infected or developing adverse outcomes following infection
Hygiene etiquietteteach symptomatic patients to cover mouth and nose when sneezing and coughing, correct use and disposal of tissues, wearing of surgical mask if tolerated, or maintaining spatial separation (if possible more than 3 feet)

Patient Placement

SINGLE ROOM – promotes reinforcement of infection control measures; should be prioritised for isolating individuals with communicable diseases or epidemiologically important organisms, to avoid exposing immunosuppressed patients to such organisms. A patient placed in a single room should:

  • have an isolation notice displayed on the door
  • have an ensuite bathroom
  • have its door closed at all times
  • have limited staff entering the room
  • be provided with psychological support and reassurance whilst in isolation
  • not have staff with infections to provide patient care
  • not have staff to provide patient care whilst providing care to infectious patients in the same duty shift

SINGLE ROOM + HIGH EFFICIENCY PARTICULATE AIR (HEPA) FILTERS – promote reduction of risk to healthcare associated infections due to airborne fungi such as Aspergillus Genus (especially where construction-related work is in progress).

Patient Hygiene

FATIGUE – Immunosuppressed patients are often fatigued. Thus, patient hygiene must be assessed on a daily basis, and assistance must be provided where necessary.

PERINEAL CARE – Immunosuppressed patients frequently suffer from irritation or infection in the perineal area – an area which would be heavily colonised with bacteria. Thus, particular attention to this area is a must to maintain patient hygiene. Note that the use of soap may irritate the mucous membranes, leading to irritation exacerbation.

STAFF ILLNESS – immunosuppressed patients should not be nursed by staff with known or suspected infections or communicable diseases eg. oral-facial herpes simplex and upper respiratory tract infections; contact between such individuals should be reported to the infection control team and to the patient’s medical consultant.

Hand Hygiene

infection control measures
Retrieved from http://www.ivicourse.com/wp-content/uploads/2017/01/Hand_Hygiene_Policy.pdf on 2nd April 2022
infection control measures
Retrieved from https://www.hha.org.au/hand-hygiene/5-moments-for-hand-hygiene on 2nd April 2022
infection control measures
Retrieved from https://www.slideserve.com/trina/are-your-hands-clean on 2nd April 2022

Environment and Equipment

  • Removal of dust from surfaces may help prevent infection (routine use of chemical disinfectant has not yet been proven to reduce infection) – surfaces need to be damp-dusted daily with single use cleaning cloths and neutral detergent; mop head needs to be laundered daily
  • Isolation rooms require cleaning with the use of gloves and aprons, followed by hand hygiene prior to leaving the room
  • Vacated rooms must be cleaned thoroughly before they are reoccupied
  • Medical equipment should be decontaminated after each use
  • Single-use items must be discarded and not re-used
  • Toys of immunosuppressed children should be decontaminated
  • Flowers and plants have not been directly linked to infection in immunosuppressed patients, however, are usually not permitted since they may act as a reservoir for Gram Negative bacteria or fungal spores like Aspergillus

Personal protective equipment

  • Use of face masks is not known to prevent infection in immunosuppressed patients, but can help protect healthcare staff from body fluid splashing
  • Routine use of non-sterile gloves and aprons/gowns may help in preventing acquisition of micro-organisms
  • PPEs must be minimally used to prevent contact with body fluids or contaminated items, and when in contact with non-intact skin and mucous membranes
  • Must be removed and discarded of as clinical waste after use, followed by application of hand hygiene
  • Sterile gloves are only required in certain aseptic or invasive procedures, or when in contact with sterile sites

Nutrition

  • Immunosuppressed patients have an increased risk of acquiring food-borne illnesses and harmful micro-organisms, and so, should be advised to avoid high-risk foods such as shellfish, pate’, soft cheeses and foods that are made with raw eggs
  • Neutropenic individuals have an increased risk of acquiring infection from Gram-Negative bacteria which is commonly found in sink plugholes and overflow outlets

Immunosuppressed Patient Visitors

Visitors should:

  • report to a staff member prior to entering the patient’s room so precautions can be explained, and infections that may pose danger for the patient may be identified
  • not visit if they have any transmissible infection
  • not bring any pets, and plants or flowers (fresh or dried)

Did you find the above nursing information useful? Follow us on Facebook and subscribe to receive new blogposts by email as soon as they’re published 🙂


Spread the love

Metabolic Syndrome and Obesity

Spread the love

Obesity is a disease which involves excessive body fat that increases the risk of additional diseases and health issues, such as cardiovascular disease, diabetes, hypertension, and cancer. Metabolic syndrome is closely linked to obesity and inactivity, as well as insulin resistance.

Retrieved from https://twitter.com/gainalliance/status/854273300389916672?lang=bn on 28th March 2022

Obesity

Obesity is “a chronic relapsing progressive disease progress” (Bray et al., 2017). It is determined by the following factors:

  1. Energy Balance
  2. Obesogenic Environment
  3. Nature VS Nurture

eNERGY BALANCE

Energy In (dietary intake) VS Energy Out (physical activity)

Obesogenic Environment

An environment that promotes weight gain and is not conducive to weight loss.

Nature vs Nurture

Genes affect the metabolic rate, fuel use, brain chemistry, and body shape. Over-eating is learned earlier on in childhood eg. encouraging child to eat whatever is on the plate. Environmental factors add to weight gain influences. Social status affects weight status eg. poverty may lead to unhealthy food choices.

Nutrition Assessment of Obesity

Obesity is characterised by excessive body fat: women with >35% body fat and men with >25% body fat. Excessive body fat puts the individual at increased risk for health problems. Body fat is calculated by measuring skin folds using calipers.

BMI calculation = weight (kg) / height (m2). BMI should ideally be between 18.5 and 24.9kg/m2

Retrieved from https://bjcardio.co.uk/2014/11/obesity-module-1-management-in-primary-care/4/ on 28th March 2022
Retrieved from https://www.researchgate.net/publication/346569912_Obesity_Weight_Loss_and_Cardiovascular_Risk/figures?lo=1&utm_source=google&utm_medium=organic on 28th March 2022

Obesity Health Risks

(Adapted from Bray GA. Gray DS, Obesity, part 1: Pathogenesis. West J Med 149:429, 1988; and Lew EA, Garfinkle L; Variations in mortality by weight among 750,000 men and women. J Clin Epidemiol 32:563, 1979.) Retrieved from https://slideplayer.com/slide/5330508/ on 28th March 2022

Android vs Gynoid Body Fat Distribution

ANDROID

  • obesity centered in the upper-body area – apple shape
  • abdominal fat is released into the liver
  • associated with cardiovascular disease, hypertension and type 2 diabetes
  • related hormone at play – testosterone

GYNOID

  • obesity centered in the lower-body area – pear shape
  • not as risky as android
  • related hormones at play – estrogen and progesterone
Retrieved from https://edu.glogster.com/glog/android-and-gynoid-body-types/2b8qtfg5144 on 28th March 2022
Retrieved from http://www.myhealthywaist.org/index.php?id=56&tx_nurebook_pi1[page]=9&cHash=644d9e5b11 on 28th March 2022

Health Problems Associated with Obesity

  • cardiovascular disease
  • hypertension
  • type 2 diabetes
  • pulmonary disease
  • cancer of the breast,colon, pancreas and gallbladder
  • sleep apnea
  • gallstones
  • bone/joint disorders
  • infertility
  • difficult delivery following pregnancy
  • increased surgical risk
  • reduced agility
  • poor quality of life
  • early death
Retrieved from https://slidetodoc.com/obesity-pathophysiology-risk-assessment-and-prevalence-obesity-excessive/ on 29th March 2022
In women, the incidence of coronary heart disease increased with increasing body mass index levels for both age groups. Among women older than 50 years, the heaviest group experienced 292 incidents of coronary heart disease compared with 223 in the BMI group < 25. In women younger than 50 years of age, the group of 30+ BMI experienced 179 incidents compared with only 76 in the < 25 BMI category. BMI Levels. Adapted from Hubert HB et al. Circulation 1983;67: Metropolitan Relative Weight of 110 is a BMI of approximately 25. Retrieved from https://slideplayer.com/slide/5330508/ on 29th March 2022
Obesity as an independent risk factor for cardiovascular disease was reexamined by Helen Hubert in the 5,209 men and women of the original Framingham cohort. Observations of disease occurrence over the 26 years indicate that obesity was an independent predictor of CVD, particularly among the younger members of the cohort and in women more than men. This study also showed that weight gain after the young adult years conveyed an increased risk of CVD in both sexes that could not be attributed to the initial weight or the levels of the risk factors that may have resulted from the weight gain. This slide shows the increasing incidence of coronary heart disease with increasing body mass index levels for both age groups of men. However, the gradient of risk was steeper among the younger men and women (< 50 years) . Among men younger than 50 years, the heaviest group experienced twice the risk of coronary disease compared with the leanest group. BMI Levels. Retrieved from https://slideplayer.com/slide/12116399/ on 29th March 2022

Weight Loss Benefits & Guidelines

Metabolic Syndrome and Obesity
Retrieved from https://community.jennycraig.com/healthy-habits-blog/live-life/10-ways-losing-5-10-of-your-body-weight-may-benefit-your-health/ on 29th March 2022

Adult Weight Loss…

  • total energy intake should be less than energy expenditure
  • consider diets with 600kcal/day deficit
  • consider low-fat diets alongside expert support and follow-ups for sustainable weight loss
  • keep in mind that low-calorie diets may not provide all nutritional requirements
  • include behaviour change strategies using a biopsychosocial approach and history in relation to past diet experiences as well as comorbidities
Metabolic Syndrome and Obesity
Retrieved from https://www.nice.org.uk/guidance/cg189/chapter/1-recommendations on 29th March 2022

Metabolic Syndrome

Metabolic Syndrome and Obesity
Retrieved from https://pucketteintegrativehealthcare.com/what-is-syndrome-x/ on 1st April 2022

Metabolic syndrome is a worldwide growing epidemic, affecting about 1 of every 4 or 5 adults in every country. Its incidence increases with age.

The term Metabolic Syndrome refers to a group of risk factors which increase the risk for cardiovascular disease, diabetes, stroke, and other health-related problems.

Metabolic Syndrome Risk Factors

  • hyperglycaemia
  • hypertension
  • abdominal obesity a.k.a. android obesity
  • low HDL cholesterol level
  • high triglyceride level (including individuals on treatment for high triglyceride level)
Metabolic Syndrome and Obesity
Retrieved from https://www.researchgate.net/publication/297600439_A_clinical_perspective_of_obesity_metabolic_syndrome_and_cardiovascular_disease/figures?lo=1 on 1st April 2022

WHO Recommendations

Metabolic Syndrome and Obesity
Retrieved from https://adamvirgile.com/2021/01/19/world-health-organization-2020-guidelines-n-physical-activity-and-sedentary-behaviour/ on 1st April 2022

Insulin Resistance

While a third of all individuals with Metabolic Syndrome have normal insulin sensitivity, the two are still associated with each other. Insulin resistance features high plasma insulin concentration which fails to suppress plasma glucose as normally happens. Contributing factors include unresponsiveness to insulin at a cellular level due to receptor-based mechanisms.

Hypertension

Insulin resistance and hyperinsulinaemia may cause hypertension due to an increase in catecholamine activity, as happens with increased insulin concentration through insulin-mediated renal tubular reabsorption of sodium. Weight loss helps in improving both hypertension and hyperinsulinaemia.

Dyslipidaemia

High trygliceride and low HDL cholesterol levels are key factors for metabolic syndrome, both commonly leading to cardiovascular disease. The term dyslipidemia refers to an increase in plasma cholesterol, triglycerides, both, or low HDL cholesterol level which leads to atherosclerosis development.

Preventing or Reversing Metabolic Syndrome

Reference

Bray, G.A., Kim, K.K., & Wilding, J.P.H. (2017). Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obesity Reviews, 18: 715-723.


Did you find the above nursing information useful? Follow us on Facebook and subscribe to receive new blogposts by email as soon as they’re published 🙂


Spread the love

Diabetic Foot

Spread the love

The diabetic foot is prone to complications, as clearly indicated by the high number of hospital admissions amongst individuals with diabetes due to foot problems. What may seem like a ‘simple’ foot ulcer can easily lead to an amputation. Sadly, a leg is amputated every 30 seconds, with up to 70% of all leg amputations happening to individuals with diabetes. Yet up to 85% of amputations can be avoided with preventative measures and adequate care.

diabetic foot conditions assessment
Retrieved from https://www.medicostuff.com/category/medicine/diabetes-mellitus/ on 26th March 2022
Retrieved from https://www.diabetesfeetaustralia.org/welcome-world-diabetes-day/ on 2nd July 2022
Retrieved from https://www.diabetesfeetaustralia.org/diabetic-foot-disease-is-a-top-10-cause-of-global-disability/ on 2nd July 2022

Diabetic Foot Ulcers – Treat as an Aggressive Cancer!

Diabetic foot complications, including amputations, can be avoided by:

  1. applying a preventative approach through cost-effective strategies
  2. identifying high risk individuals and providing them with related health literacy eg. to check their feet daily, dry them thoroughly, and wear appropriate footwear
  3. knowing when a diabetic foot ulcer has become a complicated lesion: ischaemia and infection
  4. knowing which and when to apply a proper off-loading device
  5. providing continuity in treatment and management between hospital and the community, along with organisation and communication between both settings

However…

  • 5% of individuals with new ulcers die within 12 months following their first physician visit regarding a foot ulcer
  • 42.2% of individuals with foot ulcers die within 5 years
  • 70% of diabetic foot ulcers recur over the following 3 years

“When people with diabetic foot ulcers heal, just like with cancer, they are not really healed. Our patients are in remission. We tend to think about wounds when they are open but why don’t we think about them when they are closed?

We should be aiming for having people at home in diabetic foot remission monitoring themselves”

Armstrong, Boulton and Bus, 2017.
Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S1067251607600015 on 2nd July 2022

Diabetic Foot Lesions Risk Factors

Retrieved from https://www.wjgnet.com/1948-9358/figures/v6/i1/37.htm on 2nd July 2022
Retrieved from https://www.researchgate.net/publication/242514797_DIABETIC_FOOT_DISORDERS/figures?lo=1 on 2nd July 2022

Routine Diabetic Foot Screening

1. COLLECT MEDICAL HISTORY

  • ask regarding any previous foot ulcers or lower extremity amputations
  • assess regarding poor access to healthcare and financial constraints
  • ask if patient is experiencing foot issues eg. foot pain (walking or resting), numbness, claudication (pain whilst walking or using arms – may be a symptom of peripheral artery disease)
  • ask if patient is experiencing dyspnoea
  • ask if patient has end stage renal disease

2. INSPECT & ASSESS FOOT

  • assess skin colour, temperature, and for callus or oedema presence
  • assess for lesions such as pre-ulcerative signs, active ulcers, fissures, cracks and blisters
  • check for bone and joint deformities eg. claw or hammer toes, abnormal large bony prominences, or limited joint mobility
  • check if patient is using ill-fitting or inadequate footwear
  • inspect patient feet for poor feet hygiene eg. improperly cut toenails, unwashed feet, superficial fungal infections, or unclean socks
  • notice any patient physical limitations that may hinder proper foot care eg. obesity, visual impairment, etc.
  • question patient on foot care health literacy – see what patient education is required for better self-care

3. ASCERTAIN PATIENT UNDERSTANDING & EDUCATION

  • explain the screening process and the rationale behind it
  • provide reassurance in case of anxiety
  • provide patient education, counseling and support whilst screening the patient’s feet
  • following screening, provide results to the patient, including any risks for foot problems, both in verbal and written form, along with contact details in case of any future questions

Peripheral Arterial Disease

Peripheral arterial disease is the main cause of delayed healing in the diabetic foot, associated with neuropathy in about 80% of all cases:

  • macroangiopathy – similar to atherosclerosis, but is distributed in the distal segments of the lower extremities i.e. the calf and foot arteries
  • arterial calcification – ‘hardening of the arteries’ – calcium forms hard crystals in the blood vessel walls
  • microangiopathy – thickening of the capillary basement membrane which compromises gaseous exchange

Assessing Dorsalis Pedis & Posterior Tibial Pedal Pulses

  • absence of both pedal pulses on one foot strongly suggests pedal vascular disease
  • if no pulse can be located, refer patient to a vascular specialist or a relevant health professional for further assessment

NOTE: further examinations which need to be performed by a trained healthcare professional include the Ankle Brachial Pressure Index (ABPI), Systolic Toe Blood Pressure (STBP), and the Toe Brachial Pressure Index (TBPI)

Retrieved from https://journals.rcni.com/nursing-standard/leg-ulceration-part-2-patient-assessment-ns2004.09.19.2.45.c3699 on 2nd July 2022

Diabetic Neuropathy

Up to 70% of individuals with diabetes have mild to severe forms of nervous system damage. This includes:

  • impaired sensation or pain in extremities
  • slow food digestion in the stomach
  • carpal tunnel syndrome
  • other nerve issues

With diabetic peripheral neuropathy, one may not be able to feel:

  • temperature changes
  • pressure
  • pain
  • vibration

NOTE: individual with peripheral neuropathy may also experience painful sensory neuropathy which includes burning and tingling sensations a.k.a. paresthesia.

The Motor Neuropathic Diabetic Foot

Neuropathic foot features include:

  • predominant neuropathy
  • adequate circulation
  • palpable pulses
  • warm, dry, and often painless

Complications include:

  • muscle weakness
  • muscle twitching
  • muscle paralysis
  • neuropathic ulcer commonly found at the sole of the foot
  • charcot foot
  • neuropathic oedema

Neuropathic Ulcer

Charcot Foot

Charcot foot is a condition that causes bones in the foot to weaken, leading to fractures and shape changing. This typically occurs in individuals with neuropathy.

Retrieved from https://peninsulapod.com/charcot-foot/ on 26th March 2022

Neuropathic Oedema

The Neuro-Ischaemic Diabetic Foot

Neuro-Ischaemic foot features include:

  • neuropathy
  • absent foot pulses
  • feels cool to touch
  • thin, shiny, hairless skin
  • subcutaneous tissue atrophy
  • increased pain at rest (may be absent due to neuropathy)
diabetic foot conditions assessment
Left: Neuropathic foot with prominent metatarsal heads and pressure points over the plantar forefoot. Right: Neuroischaemic foot showing pitting oedema secondary to cardiac failure, and hallux valgus and erythema from pressure from tight shoe on medial aspect of first metatarsophalangeal joint – Retrieved from https://europepmc.org/article/med/16484268 on 26th March 2022

The Ischaemic Diabetic Foot

Ischaemic foot features include:

  • peripheral vascular disease
  • absent signs of peripheral neuropathy
  • cold, shiny, hairless skin
  • rare in diabetic patients
diabetic foot conditions assessment
Retrieved from https://en.wikipedia.org/wiki/Ischemia on 26th March 2022

Diabetic Foot Assessment

To perform a diabetic foot assessment, shoes, socks, and any would dressings from both feet should be removed. This should be followed by a thorough examination for evidence of the following risk factors:

  • ulcers
  • callus
  • gangrene
  • deformity
  • infection
  • inflammation
  • charcot foot
  • limb ischaemia
  • neuropathy

Wound Assessment and Description

Retrieved from https://slideplayer.com/slide/12696492/ on 27th March 2022
Retrieved from https://www.researchgate.net/publication/311988179_Triangle_of_Wound_Assessment_Made_Easy_Revisited/figures on 27th March 2022

Assessing Sensation with a tuning fork

Assessing for Neuropathy using 10g Monofilament

Assessing for Vascular Problems

  1. Is lower limb blood supply adequate for normal function and tissue viability?
  2. Can you identify any arterial or venous vascular problems which may compromise the current state of the tissues?
  3. Are there any vascular abnormalities that may affect the patient’s healing or treatment options?
  4. What can you do to avoid possible complications?
  5. Does the patient have a vascular condition that requires further investigations by a specialist?

Calculating Ankle-brachial index

Retrieved from https://www.researchgate.net/publication/233765986_Anklebrachial_index_to_everyone/figures?lo=1 on 27th March 2022

Osteomyelitis

Foot Ulcer Treatment – Key Elements

  1. providing local wound care
  2. providing pressure relief for ulcer protection
  3. providing infection treatment
  4. restoring skin perfusion
  5. preventing recurrence
  6. treating or controlling other comorbidities eg. diabetes
  7. providing related health literacy to patients and their relatives

Provide the patient with oral and written information in detail, including information about diabetes control, foot emergencies, and contact person details.

Offloading

Offloading promotes reduction, redistribution, or removal of detrimental forces applied to the foot. Offloading alleviates pressure at areas of high vertical and shear stress.

Foot plantar pressure is the pressure field which acts between the foot and the support surface during everyday activities. The main aim of offloading devices is to redistribute plantar pressures evenly, which helps avoid areas of high pressure that prevent or delay healing.

A, Total contact cast; B, Charcot Restraint Orthotic Walker boot; C, prefabricated walker; D, DH walker; E, IPOS shoe; F, OrthoWedge; G, postoperative shoe; H, healing sandal; I, reverse IPOS; J, L’nard splint; K, patella tendonbearing brace; L, MABAL shoe. 1, Dorsal digit; 2, plantar digit; 3, plantar metatarsal; 4, medial metatarsal; 5, lateral metatarsal; 6, heel.

Retrieved from https://www.researchgate.net/publication/269766812_The_Management_of_Diabetic_Foot_Ulcers_Through_Optimal_Off-Loading_Building_Consensus_Guidelines_and_Practical_Recommendations_to_Improve_Outcomes/figures?lo=1 on 3rd July 2022

References

Armstrong, D., Boulton, A., & Bus, S. (2017). Diabetic Foot Ulcers and Their Recurrence. The New England Journal of Medicine, 376(24), 2367-2375. Retrieved from http://81.143.226.227/Medicine/Papers/2017_06_15%20NEJM%20Diabetic%20Foot%20Ulcers%20and%20Their%20Recurrence.pdf on 2nd July 2022.


Did you find the above nursing information useful? Follow us on Facebook and subscribe to receive new blogposts by email as soon as they’re published 🙂


Spread the love

Diabetes Prevention and Management

Spread the love

Type 2 Diabetes prevention aims to prevent or delay the onset of diabetes, or to prevent complications arising from Type 2 Diabetes. For diabetes prevention it is recommended that:

  1. individuals are first assessed for the risk of prediabetes through an adequate risk assessment tool such as the German Diabetes Risk Score
  2. if high risk result is achieved, the individual should be tested for prediabetes or Type 2 Diabetes
  3. individuals found with prediabetes should have their blood glucose monitored every year
diabetes prevention and management
Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK535456/figure/article-18425.image.f1/ on 21st March 2022
diabetes prevention and management
Retrieved from https://dryatendrayadav.com/2018/10/17/measure-waist-measure-risk/ on 21st March 2022
diabetes prevention and management
Retrieved from https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/simple-cutoff-for-waisttoheight-ratio-05-can-act-as-an-indicator-for-cardiometabolic-risk-recent-data-from-adults-in-the-health-survey-for-england/5D882EE63FA4B3C530B48D6232BDB355 on 21st March 2022

Diabetes Prevention and Delay

Lifestyle Changes

Type 2 Diabetes can be prevented or delayed by:

  • intensive lifestyle behaviour change programmes (include a calorie-reduced diet coupled with exercise – also promote reduction of risk factors such as hypertension, hyperlipidaemia, and inflammation)
  • achievement and maintenance of 7% loss of body weight
  • physical activity such as brisk walking for at least 150 minutes per week

Pharmacological Therapy

Prevention of Type 2 Diabetes can also be assisted with pharmacological therapy, where individuals with a BMI of 35kg/m2 AND/OR who have 60 years or more AND/OR women with past GDM (gestational diabetes mellitus) can be prescribed Metformin.

NOTE: long term use of Metformin has been associated with vitamin B12 deficiency, therefore, vitamin B12 levels should be monitored on a regular basis especially in individuals with peripheral neuropathy and/or anaemia.

Diabetes Management

Nutrition

Eating a healthy balanced diet promotes:

  • weight control
  • blood glucose level stabilisation
  • serum lipid level decrease

A patient with diabetes should be encouraged reduce sugar intake to a minimum, to reduce carb intake, and to distribute caloric intake throughout the day in smaller meals with snacks in between. This helps to reduce the chance of experiencing a hypoglycaemic episode. Carbs which are high in fibre are a better choice.

Retrieved from https://www.hsph.harvard.edu/nutritionsource/healthy-eating-plate-vs-usda-myplate/ on 22nd March 2022

Exercise

A 30-minute walk per day promotes better Diabetes management. Exercise:

  • lowers blood glucose level
  • promotes weight loss
  • reduces blood lipids
  • decreases the blood pressure
  • promotes better circulation

Caution should be taken:

  • when the individual is using insulin since hypoglycaemia can occur during exercise OR up to several hours after exercise; patient should be encouraged to check blood glucose before and after exercising
  • if the individual’s urine contains ketones and blood glucose is over 14mmol/l
  • if the individual has other complications such as cardiovascular disease, neuropathy and retinopathy
  • patient should be encouraged to keep a blood glucose diary, listing down blood glucose values as well as when it was taken (before/after meal/exercise) so as to evaluate results and see if any changes in individualised care plan are necessary

Pharmacological Therapy

Type 1 Diabetes Management

An individual’s daily amount of needed insulin is calculated on the person’s weight: 0.4 to 1.0 units per kg per day. About 50% of the total amount of insulin needed per day is given as basal, while the other half is given in relation to food intake a.k.a. prandial.

Rapid acting insulin helps in reducing the risk of hypoglycaemia. Patient education is recommended with regards to bolus insulin dose adjustment prior to meals, based on carbohydrate intake, blood glucose, and exercise.

Lantus is long-acting, usually with no peak. It is taken ideally at bedtime or else early in the morning.

Actrapid is a short-acting insulin which works rapidly. It peaks in 2-3 hours with a duration of 5-8 hours. Actrapid is usually recommended to be administered 30 minutes before eating.

Patient on insulin should be instructed to:

  • always check blood glucose after washing hands with soap and water and not use alcohol rub; to use the lancet at the side of the finger and to wipe and discard first drop of blood before testing with the 2nd drop
  • check blood glucose 30 minutes before eating or 2 hours after eating
  • taught how the prescribed medications work
  • told when to administer insulin to self
  • told to rotate injection site every time
  • told to carry glucose or sugar in case a hypoglycaemic episode is experienced
  • told to store opened insulin vials in a dark cupboard away from sunlight and to discard after 30 days
  • told to store unopened insulin vials in the fridge
  • told to discard insulin if change in colour occurs, even if still unexpired, as that could be a sign that it has been denatured

NOTE: during puberty, pregnancy, and illness, higher doses of insulin need to be administered.

diabetes prevention and management
Retrieved from https://agamatrix.com/blog/different-types-of-insulin/ on 24th March 2022
Retrieved from https://www.researchgate.net/publication/332836996_Therapies_for_Type_1_Diabetes_Current_Scenario_and_Future_Perspectives/figures?lo=1&utm_source=google&utm_medium=organic on 14th June 2022

Blood glucose control depends on the technique used for insulin administration…

  • short needle (4mm pen needle)
  • correct dose
  • rotate site
  • alcohol should not be used to clean site prior to injecting insulin
  • dose should be injected subcutaneously (pinch tissue and inject at a 90 degree angle)
Retrieved from https://www.manula.com/manuals/sirma-medical-systems/diabetes-m-user-guide/mobile/en/topic/injection-sites on 24th March 2022

Insulin Pen

Continuous Subcutaneous Insulin Infusion

Type 2 Diabetes Management

Initially, a newly diagnosed diabetes type 2 patient is started on a 3 month trial of diet and exercise. Following this 3 month period, if the patient’s HbA1c still increases to 48mmol/mol (6.5%), pharmacological treatment is initiated.

FIRST LINE TREATMENT

If HbA1c = 48mmol/mol (6.5%):

  • Start on metformin (standard-release) morning + evening dose
  • Gradually increase dose (gradually = due to GI side effects)
  • In case of side effects switch to modified release metformin (evening dose)
  • If metformin tolerability is confirmed in cases where patient has CHF or CVD, Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) can be introduced
  • If metformin is contraindicated, SGLT-2i can be considered as a stand-alone medication

FIRST INTENSIFICATION

If HbA1c = 58mmol/mol (7.5%):

  • metformin and a DPP-4i (Dipeptidyl peptidase 4 inhibitor) OR
  • metformin and pioglitazone OR
  • metformin and a SU (Sulfonylurea) OR
  • metformin and a SGLT-2i (Sodium-glucose cotransporter 2 inhibitors)

PLUS consider introducing Insulin.

NOTE: aim for HbA1c 53mmol/mol (7%)

SECOND INTENSIFICATION

If HbA1c = 58mmol/mol (7.5%):

Triple Therapy is recommended…

  • insulin-based treatment OR
  • metformin + DPP-4i + SU OR
  • metformin + pioglitazone + SU OR
  • metformin + pioglitazone OR SU + SGLT-2i

NOTE: aim for HbA1c 53mmol/mol (7%)

If triple therapy is ineffective, not tolerated, or contraindicated, combine metformin + SU + GLP-1 mimetic.

(ideal for adults with type 2 diabetes with BMI 35kg/m2 or more AND adults with same BMI experiencing significant occupational implications on insulin)

Metformin

  • inhibits gluconeogenesis
  • increases uptake of glucose by body tissues
  • may prevent weight gain

To avoid GI disturbances, dose should be increased gradually.

DPP-4i (Dipeptidyl peptidase 4 inhibitor)

alogliptin, linagliptin, saxagliptin, sitagliptin, viltagliptin

  • effects of hormones released from the intestine based on food intake are prolonged
  • pancreatic insulin secretion is increased
  • no known side effects

Glitazones

pioglitazone

  • improves insulin sensitivity
  • improves beta cell function
  • does not cause GI upset
  • no added risk of hypoglycaemia
  • dose once daily

but…

action onset happens at 6 weeks or more; pioglitazone is also associated with an increased risk of heart failure, bone fracture, and bladder cancer.

Sulphonylureas

glicazide, glimepiride, gliplizide, tolbutamide

  • stimulates secretion of pancreatic insulin

but…

increases the risk for hypoglycaemia and weight gain.

SGLT-2i (Sodium-glucose cotransporter 2 inhibitors)

canagliflozin, dapagliflozin, empagliflozin, ertugliflozin

  • prevents reabsorption of glucose into the blood by the kidneys
  • causes glucose excretion through urine
  • promotes weight loss
  • dose once daily

but…

is contraindicated for patients with renal dysfunction; increases the risk of severe genital infections and UTIs; increases risk of DKA when taken and shortly after stopping them.

GLP-1 mimetic

dulaglutide, exenatide, liraglutide, lixisennatide, semaglutide

Administered via weekly subcutaneous injection.

  • inhibits glucagon secretion
  • stimulates insulin secretion
  • slows gastric emptying
  • increases beta cell mass
  • promotes weight loss

but…

commonly causes nausea (which tends to decrease by time); rarely causes acute pancreatitis.

Monitoring

  • Monitor A1c and other glycaemic factors at least twice a year in patients responding to treatment (with stable glycaemic control)
  • Monitor A1c and other glycaemic factors at least 4 times a year in patients who have had recent change in therapy and who are not meeting glycaemic goals

Average Glucose Estimation for HbA1c Values…

Retrieved from https://ptsdiagnostics.com/a1cnow-systems-overview/ on 26th March 2022

Glycaemic Targets…

Retrieved from https://www.researchgate.net/publication/338390896_Insulin_Therapy_in_Adults_with_Type_1_Diabetes_Mellitus_a_Narrative_Review/figures?lo=1 on 26th March 2022

Reference

NICE (2022). Type 2 diabetes in adults: management. Retrieved from https://www.nice.org.uk/guidance/ng28 on 26th March 2022


Did you find the above nursing information useful? Follow us on Facebook and subscribe to receive new blogposts by email as soon as they’re published 🙂


Spread the love

Diabetes Mellitus

Spread the love

Diabetes Mellitus is a metabolic disorder in which the body does not produce enough insulin, or does not respond normally to insulin, leading to hyperglycaemia – abnormally high blood sugar level a.k.a. glucose. Causes include defects in insulin secretion, insulin action, and abnormal carbohydrate, fat, and protein metabolism.

Diabetes Mellitus Pathophysiology

  1. Food is ingested
  2. The pancreas produces LESS insulin than required
  3. High level of glucose is retained in the blood
  4. Breakdown of proteins and body fats lead to production of ketones, resulting in weightloss
  5. Excess glucose is excreted in urine, causing increased urine output and excessive thirst due to osmotic diuresis
  6. In case of very low insulin availability, accumulation of ketones result in ketoacidosis

Signs & Symptoms

  • polyuria – excessive urination
  • polydipsia – excessive thirst
  • polyphagia a.k.a. hyperphagia – excessive hunger due to cells being in a state of starvation
  • weightloss
  • fatigue
  • blurred vision
  • tingling and/or numbness in extremities – usually if diagnosed at a later stage, after peripheral nerve damage has already occurred
  • slow-healing wounds
  • recurrent infections – both women and men experiencing frequent infections should be tested for diabetes

NOTE: if uncontrolled, patient appears to be drowsy and may become unconscious; severe signs of diabetes include drowsiness and coma.

Diabetes Type 1 VS Diabetes Type 2

diabetes mellitus type 1 vs diabetes mellitus type 2
Retrieved from https://www.homage.sg/health/type-1-type-2-diabetes/ on 16th March 2022

Type 1 Diabetes

In Type 1 Diabetes there are very low levels of C-peptide in the blood or urine, which at times go undetected. Insulin becomes a requirement for survival. In the worst case scenario, the diabetic person may develop diabetic ketoacidosis (DKA) – a serious complication of diabetes that can be life-threatening. In DKA, the body undergoes an auto-immune process where it destroys beta cells, leading to lack of insulin production, making it impossible for blood sugar to enter the cells to be converted into energy. A person in DKA requires immediate acute care.

Type 1 Diabetes is not related to lifestyle factors, but to genetic predisposition and environmental factors.

Type 2 Diabetes

In Type 2 Diabetes, DKA can occur in stressful situations, although quite rare (since insulin is still produced even if in small amounts). Insulin is required as a controlling measure. Risks for Type 2 Diabetes include increasing age, obesity, unhealthy lifestyle, familial predisposition, and past gestational diabetes. This type of diabetes may remain undiagnosed for a long time.

gestational diabetes

Gestational Diabetes Mellitus (GDM) is diagnosed during pregnancy in the 2nd or 3rd trimester. Diagnosis criteria includes fasting plasma glucose of 5.1-6.9mmol/L OR 1 hour post-load plasma glucose of at least 10.0mmol/L OR 2 hour post-load plasma glucose of 8.5-11.0mmol/L.

LADA – Latent Autoimmune Diabetes in Adults

LADA a.k.a. slowly evolving immune-mediated diabetes is a hybrid form of diabetes which does not require insulin upon diagnosis, but which eventually does move on to needing insulin at a much faster rate than a person with Type 2 Diabetes. A person with LADA is usually over 35 years of age on diagnosis, testing positive for GAD auto-antibodies (antibodies to glutamic acid decarboxylase).

Ketosis-Prone Type 2 Diabetes

In this type of hybrid diabetes which typically affects young African-Americans, the person presents with severe insulin deficiency and ketosis.

Other Types of Diabetes

  • MONOGENIC DIABETES includes Neonatal Diabetes, and MODY (Maturity Onset Diabetes of the Young)
  • EXOCRINE PANCREATIC INSUFFICIENCY (EPI) include pancreatitis and cancer
  • DRUG-INDUCED DIABETES such as glucocorticoids
  • INFECTIONS such as cytomegalovirus
  • MONOGENIC DEFECTS OF INSULIN ACTION
  • ENDOCRINE DISORDERS such as Cushing’s Syndrome
  • GENETIC SYNDROMES such as Down’s Syndrome and Huntington’s Chorea
  • UNCLASSIFIED DIABETES

Criteria for Asymptomatic Prediabetes and Diabetes Mellitus Testing

Prediabetes is not considered as a clinical condition. Testing for prediabetes and diabetes in asymptomatic overweight or obese individuals is recommended for those with at least one of the following risk factors:

  • diabetic first-degree relative
  • ethnicity
  • history of cardiovascular disease
  • sedentary lifestyle
  • hypertension (including individuals on anti-hypertensives)
  • low HDL Cholesterol level and/or high triglyceride level
  • women with PCOS
  • conditions related to insulin-resistance
  • HIV

NOTES:

  • Individuals diagnosed with prediabetes should be re-tested for diabetes on a yearly basis
  • Women who have had Gestational Diabetes Mellitus should be re-tested for diabetes every 3 years
  • From the age of 35, every individual should start undergoing diabetes testing. Following a normal result, testing should be repeated after 3 years unless the person is considered to be high risk

Diabetes Mellitus Diagnosis

FASTING PLASMA GLUCOSE (FPG) – blood testing following an 8 hour fasting period (a test result of 7.0mmol/L / 126mg/dl or more indicates diabetes).

Patient should have the appointment scheduled early in the morning. Hypoglycaemics should NOT be administered whilst fasting. Patients on Lantus need to take their dose in the evening, without the bonus dose in the morning; they should then check their blood glucose before they leave in the morning to ensure they are not hypoglycaemic – if they are, they need to take something and reschedule their FPG test.

About 7ml of venous blood is drawn into a red or grey top tube. Patient should eat after FBG test.


ORAL GLUCOSE TOLERANCE TEST (OGTT) – blood testing following 75g oral glucose intake 2 hours before (a test result of 11.1mmol/l / 200mg/dl or more indicate diabetes).

Encourage patient to take full 75g dose since it is difficult to ingest. Smoking affects results so tell your patient to avoid smoking.

Prior to testing day, patient should consume adequate carbohydrate intake and perform physical activity, and should eat a 30-50g carbohydrate-based meal the evening before the test and fast for 8 hours, drinking water only if necessary. Drugs may be stopped based on physician’s recommendation. Patient’s weight should be measured to determine recommended oral glucose dose.

During test, a fasting blood specimen should be taken prior to administration of oral glucose – 75g carbohydrate load (patient can drink water if needed – no smoking). Blood is drawn after 2 hours. Patient should be monitored for transient reactions such as dizziness, sweating and weakness.

Note any drugs which can impact the result on the laboratory slip and send to the lab. Patient can drink and eat as normal, and if required, insulin or oral hypoglycaemic agents can be administered if prescribed.


HAEMOGLOBIN A1c (HbA1c) – average blood glucose level testing covering the previous two to three months (a test result of 6.5% / 48mmol/mol or more indicates diabetes)

NOTE: If asymptomatic, repeat the same test on a different day. Two test results above the threshold are required for diabetes diagnosis.

Prediabetes

Prediabetes refers to the phase in which the criteria for diabetes is not met, but the glucose levels are higher than normal. It is associated with obesity, high triglyceride level, low HDL cholesterol level, and hypertension.

Whilst prediabetes is not considered to be a clinical condition, it increases the risk for diabetes as well as cardiovascular disease, and so, individuals diagnosed with prediabetes should take preventative measures to avoid progressing to type 2 diabetes.

Prediabetes is determined by the following test results:

  • FPG 100mg/dl (5.6mmol/l) to 125mg/dl (6.9mmol/l) OR
  • 2hr PG during 75-g OGTT 140mg/dl (7.8mmol/l) to 199mg/dl (11.0mmol/l) OR
  • HbA1c 5.7-6.4% (39-47mmol/mol)

Diabetes Mellitus Nursing Care Management

Additional Notes…

  • blood glucose control may be lost when the patient is going through stress, exercise, puberty, fever, etc.
  • excessive thirst is a possible warning sign for diabetes
  • sense of smell is not affected in individuals with diabetes
  • individuals with diabetes can still eat foods high in carbs as long as they make adjustments in their medication doses (as instructed by their clinician)
  • frequent urination is a possible warning sign for diabetes
  • individuals with diabetes can still exercise
  • numbness in the hands and feet is common in individuals with diabetes
  • being overweight or obese doesn’t increase the risk of getting type 1 diabetes
  • individuals with diabetes can still enjoy some sweets or ice cream (in moderation)
  • diabetes is a life threatening condition – over a century ago, having diabetes without insulin treatment being available meant having a terminal illness

Reference

World Health Organization (2019). Classification of diabetes mellitus. Retrieved from https://apps.who.int/iris/rest/bitstreams/1233344/retrieve


Did you find the above nursing information useful? Follow us on Facebook and subscribe to receive new blogposts by email as soon as they’re published 🙂


Spread the love

The Endocrine System – The Adrenal Glands

Spread the love

The adrenal glands are small triangular-shaped structures located at the top of both kidneys. Their function is to produce hormones that help in the regulation of the metabolism, immune system, blood pressure, stress response, and more.

adrenal glands
Retrieved from https://www.jaypeedigital.com/book/9789350903025/chapter/ch16 on 12th March 2022

The adrenal glands, which are covered by an inner thick layer of connective tissue with an outer thin fibrous capsule, contain two sections:

  1. OUTER ADRENAL CORTEX – makes up the biggest part of the gland
  2. INNER ADRENAL MEDULLA – the core

The OUTER ADRENAL CORTEX is made up of 3 parts:

  1. Zona Glomerulosa – makes up 15% of the total volume (secretes mineralocorticoids)
  2. Zona Fasciculata – makes up the widest part of the total volume (mainly secretes glucocorticoids)
  3. Zona Reticularis – secretes amounts of hormones, mostly gonadocorticoids and androgens
adrenal glands
Retrieved from https://www.majordifferences.com/2014/04/difference-between-adrenal-cortex-and.html on 12th March 2022

Adrenal Cortex vs Adrenal Medulla

Mineralocorticoids

Mineralocorticoids are responsible for water and electrolyte homeostasis through control of sodium and potassium concentrations. 95% of all mineralocorticoid activity happens through Aldosterone:

  1. Aldosterone acts on the kidneys’ tubule cells, causing them to increase sodium reabsorption
  2. Sodium ions are removed from the urine and returned to the blood
  3. Rapid depletion of sodium from the body is prevented

Aldosterone causes:

  • potassium excretion
  • sodium reabsorption
  • hydrogen ions elimination
  • sodium, chloride, and bicarbonate ions retention
  • water retention

NOTE: Aldosterone reduces potassium reabsorption, thus, large potassium amounts are lost in urine excretion.

Electrolyte balance Secondary Effects

Sodium retention and potassium excretion lead to secondary effects:

  • Sodium reabsorption causes Hydrogen ions to pass into the urine to replace positive sodium ions, making the blood less acidic, thus preventing acidosis.
  • Sodium ions movement creates a positively charged field in the blood vessels surrounding the kidney tubules. This causes Chloride and Bicarbonate ions to move out from urine, back into the blood.
  • When ADH (antidiuretic hormone) is present, increased sodium concentration in the blood vessels causes water to move by osmosis from the urine into the blood.

Aldosterone control #1 – the raas system

RAAS system
Retrieved from https://www.pinterest.com/pin/557813103821299549/ on 13th March 2022

Aldosterone Control #2 – Potassium Ion Concentration

  1. Increased potassium concentration in extracellular fluid causes the adrenal cortex to secrete aldosterone
  2. Aldosterone secretion causes excess potassium to be eliminated by the kidneys
  3. Decreased potassium concentration in the extracellular fluid causes a decrease in aldosterone production, leading to less potassium excretion by the kidneys

Glucocorticoids

Glucocorticoids promote normal metabolism by:

  • increasing the rate of protein catabolism
  • increasing the rate at which amino acids are removed from cells and transported to the liver to undergo protein synthesis
  • releasing fatty acids from adipose tissue to be converted into glucose
  • promoting gluconeogenesis

Glucocorticoids promote stress resistance:

  • gluconeogenesis from amino acids causes a sudden increase in glucose availability, prompting the body to become more alert
  • blood vessels become more sensitive to chemicals that cause vasoconstriction so as to allow an increase in blood pressure

Glucocorticoids are anti-inflammatory compounds:

  • cause a reduction in mast cells
  • stabilise lyosomal membranes, leading to the inhibition of histamine release
  • decrease blood capillary permeability
  • depress phagocytosis by monocytes

Glucocorticoids:

  • Cortisol (hydrocortisone) – most abundant and responsible for about 95% of all glucocorticoid activity
  • Corticosterone
  • Cortisone

NOTE: Cortisol Serum blood test indicates adrenal function.

NOTE: Glucocorticoids slow down connective tissue regeneration, which leads to slow wound healing.

NOTE: Steroids are a synthetic form of glucocorticoids.

ACTH (Adrenocorticotropic hormone) Control

Glucocorticoid secretion is controlled through a negative feedback mechanism stimulated by stress and low blood glucocorticoid level:

  1. stress and low blood glucocorticoid level stimulate the hypothalamus to secrete CRF (corticotropin releasing factor)
  2. CRF secretion causes ACTH to be released from the anterior lobe of the pituitary
  3. ACTH is carried to the adrenal cortex, where it stimulates glucocorticoid secretion
adrenal glands
Retrieved from https://quizlet.com/279451837/chapter-9-vocabulary-flash-cards/ on 13th March 2022

Gonadocorticoids

The adrenal cortex is responsible for the secretion of both male and female sex hormones – oestrogens and androgens.

Adrenal Medulla

  • The adrenal medulla is made up of chromaffin cells (hormone-producing cells) surrounding sinuses containing blood
  • These chromaffin cells are considered to be postganglionic cells specialised in secretion
  • Preganglionic fibres pass directly into the chromaffin cells of the gland within the adrenal medulla
  • Secretion of hormones is controlled by the autonomic nervous system and innervation by preganglionic fibres that allows rapid response to a stimulus by the gland

Epinephrine and Norepinephrine

The adrenal medulla synthesises the following two hormones:

  • Epinephrine (adrenaline)
  • Norepinephrine (noradrenaline)

Epinephrine is stronger than norepinephrine. It:

  • increases the blood pressure by increasing the heart rate and constricting the blood vessels
  • increases respiration rate
  • dilates respiratory passageways
  • decreases digestion rate
  • increases muscular contraction efficiency
  • increases blood sugar level
  • stimulates cellular metabolism

However, both epinephrine and norepinephrine:

  • mimic the sympathetic nervous system – they are sympathomimetic
  • help in stress resistance

Did you find the above nursing information useful? Follow us on Facebook and fill in your email address below to receive new blogposts in your inbox as soon as they’re published 🙂


Spread the love